Gain comprehensive, actionable guidance on the FDA’s classification of high throughput DNA sequencing for hereditary cancer predisposition assessment test systems. This course details the specific Class II (special controls) regulatory requirements—covering design verification, validation, and labeling—that manufacturers and laboratories must meet to ensure market access, patient safety, and legal compliance. Learn the steps for successful 510(k) premarket notification, documentation, and ongoing quality management to avoid costly enforcement actions and maintain uninterrupted device availability.
In this course you will learn the following:
* Understand the scope and intent of the FDA’s final rule for these test systems.
* Identify the key special controls and general controls required for compliance.
* Implement the necessary design, validation, and labeling requirements.
* Recognize the legal and regulatory consequences of failing to comply with the new classification.
